Intech Investment Management LLC raised its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) by 129.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 40,463 shares of the semiconductor company’s stock after purchasing an additional 22,792 shares during the period. Intech Investment Management LLC’s holdings in Axcelis Technologies were worth $3,251,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also bought and sold shares of ACLS. Close Asset Management Ltd bought a new stake in Axcelis Technologies during the 3rd quarter valued at $27,000. EverSource Wealth Advisors LLC raised its position in Axcelis Technologies by 145.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 451 shares of the semiconductor company’s stock valued at $31,000 after purchasing an additional 267 shares in the last quarter. Caitlin John LLC bought a new stake in Axcelis Technologies during the 3rd quarter valued at $32,000. Advisory Services Network LLC bought a new stake in Axcelis Technologies during the 3rd quarter valued at $32,000. Finally, Leonteq Securities AG bought a new stake in Axcelis Technologies during the 4th quarter valued at $40,000. 89.98% of the stock is owned by institutional investors.
Axcelis Technologies Stock Up 0.0%
NASDAQ:ACLS opened at $150.42 on Tuesday. Axcelis Technologies, Inc. has a fifty-two week low of $56.19 and a fifty-two week high of $171.61. The stock has a market capitalization of $4.62 billion, a P/E ratio of 46.86, a P/E/G ratio of 10.65 and a beta of 1.91. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.99 and a current ratio of 4.59. The company’s 50-day simple moving average is $129.61 and its 200-day simple moving average is $101.44.
Wall Street Analysts Forecast Growth
ACLS has been the subject of a number of research analyst reports. Zacks Research raised Axcelis Technologies from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Weiss Ratings lowered Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Tuesday, May 12th. Finally, B. Riley Financial raised Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 price target for the company in a research report on Monday, April 20th. Three research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $116.25.
Read Our Latest Stock Report on ACLS
Insider Activity at Axcelis Technologies
In related news, CEO Russell Low sold 7,468 shares of the company’s stock in a transaction dated Wednesday, May 6th. The stock was sold at an average price of $156.75, for a total transaction of $1,170,609.00. Following the transaction, the chief executive officer directly owned 123,570 shares of the company’s stock, valued at $19,369,597.50. This represents a 5.70% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gregory B. Graves sold 3,225 shares of the company’s stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $141.61, for a total value of $456,692.25. Following the transaction, the director directly owned 5,473 shares in the company, valued at $775,031.53. This represents a 37.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 34,453 shares of company stock worth $5,211,694 over the last ninety days. Corporate insiders own 0.49% of the company’s stock.
About Axcelis Technologies
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
Further Reading
- Five stocks we like better than Axcelis Technologies
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report).
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
